Transcriptome profiling data of 300 GC samples and corresponding survival outcomes obtained from the ACRG study showed that the Overall survival (OS), Recurrence‐Free‐Survival (RFS) and Disease‐Free‐Survival (DFS) of ALKBH5 high group were shorter (Figure 1F–H). The gene discussed is ALKBH5; the disease is gastric cancer.